Project Summary and
In the absence of agreed guidelines the management of lung cancer
varies from institution to institution. Controlled studies have
demonstrated no significant survival advantage between established
therapies in common use. There is a lack of data to indicate how these are
applied in non-specialist settings and no information about quality of
life outcomes or resource consequences, which are crucial to evaluating
the cost benefit ratio of management policies.
This study aims to expand on an earlier audit to compare prospectively,
the management processes and outcome (in terms of symptom control, quality
of life, survival and resource utilisation) for an unselected series of
new patients referred to chest physicians, diagnosed as having lung cancer
and managed in three different clinical care settings, i.e. district
general hospital, teaching hospital and regional cancer centre. The
ultimate aim of the study is to provide systematic data to inform future
treatment and supportive care strategies to ensure optimal patient
outcomes and resource use.
||To assess and compare the characteristics of
patients selected for curative/palliative/supportive therapy by
respiratory physicians in DGH versus academic centres.
||To assess and compare the primary treatment decision for each
category of patient (i.e. curative/palliative/supportive care) in
the DGH versus academic centre.
||To assess and compare characteristics of patients
whose lung cancer is primarily managed by clinicians in the DGH
versus academic centre versus oncology centre.
||To assess and compare the outcome of treatment 1 month, 3 months
and 6 months post diagnosis of lung cancer patients whose care is
organised by each centre.
||To compare the survival time for lung cancer
patients primarily managed by each of the 3 centres.
||To identify and cost resources used by each patient in order to
compare the resource use consequences of management practices for
each category of patient in each of the 3 settings.
Poster presentation. The 1st European Conference on the
Economics of Cancer. Palais de Congres, Brussels, Belgium. November
information may be obtained from:
Dr Ann Cull
Consultant Clinical Psychologist
c/o Department of Clinical Psychology
Western General Hospital
Edinburgh EH4 2XU